JPWO2020179868A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020179868A5
JPWO2020179868A5 JP2021503646A JP2021503646A JPWO2020179868A5 JP WO2020179868 A5 JPWO2020179868 A5 JP WO2020179868A5 JP 2021503646 A JP2021503646 A JP 2021503646A JP 2021503646 A JP2021503646 A JP 2021503646A JP WO2020179868 A5 JPWO2020179868 A5 JP WO2020179868A5
Authority
JP
Japan
Prior art keywords
nucleotide sequence
bacteria
antibacterial composition
inflammation
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021503646A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020179868A1 (https=
JP7488581B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/009423 external-priority patent/WO2020179868A1/ja
Publication of JPWO2020179868A1 publication Critical patent/JPWO2020179868A1/ja
Publication of JPWO2020179868A5 publication Critical patent/JPWO2020179868A5/ja
Application granted granted Critical
Publication of JP7488581B2 publication Critical patent/JP7488581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021503646A 2019-03-07 2020-03-05 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物 Active JP7488581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815101P 2019-03-07 2019-03-07
US62/815,101 2019-03-07
PCT/JP2020/009423 WO2020179868A1 (ja) 2019-03-07 2020-03-05 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物

Publications (3)

Publication Number Publication Date
JPWO2020179868A1 JPWO2020179868A1 (https=) 2020-09-10
JPWO2020179868A5 true JPWO2020179868A5 (https=) 2023-03-10
JP7488581B2 JP7488581B2 (ja) 2024-05-22

Family

ID=72338206

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021503646A Active JP7488581B2 (ja) 2019-03-07 2020-03-05 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物

Country Status (8)

Country Link
US (2) US20220125858A1 (https=)
EP (1) EP3957367B1 (https=)
JP (1) JP7488581B2 (https=)
CN (1) CN113573780B (https=)
AU (1) AU2020232066B2 (https=)
CA (1) CA3125323A1 (https=)
TW (1) TWI843817B (https=)
WO (1) WO2020179868A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024185738A1 (https=) * 2023-03-07 2024-09-12
CN118146998B (zh) * 2024-03-14 2024-08-27 广东悦创生物科技有限公司 一株长双歧杆菌长亚种ks1及其在制备抗衰老和助睡眠药品中的应用
CN119842563B (zh) * 2025-03-17 2025-06-06 昆明医科大学第一附属医院(云南省皮肤病医院) 多尔氏菌emf18-06b1d及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
JP5300772B2 (ja) * 2010-03-26 2013-09-25 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
US9408878B2 (en) * 2010-12-17 2016-08-09 Compagnie Gervais Danone Lactococcus lactis strains for use in improving digestive condition
US12285475B2 (en) 2016-11-01 2025-04-29 Keio University Bacterium capable of inducing TH1 cells
AU2018302641B2 (en) 2017-07-18 2024-12-19 Keio University Anti-bacterial composition against Th1 cell-inducing bacteria
EP3723776A4 (en) * 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms

Similar Documents

Publication Publication Date Title
US11452765B2 (en) Sequence specific antimicrobials
JP2021078504A5 (https=)
JPWO2020179868A5 (https=)
Huff et al. Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens
JP2022541795A5 (https=)
BR112013016690A2 (pt) agente para induzir a produção de ifn, agente imunopotencializador, agente para prevenção ou tratamento de infecção viral, produto comestível ou bebível, método de triagem de bactérias do ácido lático, microrganismo hospedeiro para uma vacina recombinante
SA520420620B1 (ar) أوليجونيوكليوتيد مزدوج الجديلة محدد بجين أمفيرجولين وتركيبة للوقاية من وعلاج الأمراض المرتبطة بالتليف وأمراض الجهاز التنفسي تشتمل عليه
EP2494059A4 (en) USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY
JP2014518849A5 (https=)
EP2373693A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF ORAL INFECTIONS BY E. COLI
CN110114083A (zh) 一种预防和治疗脂肪肝的方法
JP2023548581A5 (https=)
JP2017526627A5 (https=)
JP2004533246A5 (https=)
RU2013114313A (ru) Противокариесные композиции и пробиотики/пребиотики
JP2012530073A5 (https=)
CN114340609A (zh) 产生安全量的一氧化氮的药物组合物及其用途
JP2017519730A5 (https=)
CN111315886A (zh) 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物
JP2013539776A5 (https=)
WO2020099478A3 (en) Angptl4 oligonucleotides influencing the regulation of the fatty acid metabolism
KR101802447B1 (ko) 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물
CN115551535A (zh) 一种治疗脊髓性肌萎缩症的方法和药物
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
BR112022009834A2 (pt) Oligonucleotídeo de fita dupla ctgf-específico, constructo, nanopartículas e composições farmacêuticas para prevenir ou tratar fibrose e doenças respiratórias e formulações liofilizadas